The fact that known oncogenic mutations of H-RS cells are also frequently found in other hematological malignancies fits with our finding of mGluR5 in different lymphoma subtypes—implying that we are pursuing the hypothesis of a tumor-promoting function of mGluR5 together with a potential role in the development of autoantibodies [16]. This evidence concerns the gene GRM5 and hematologic disorder.